首页 > 市场调查报告书 > 医疗设备

药物递输设备

市场调查报告书

商品编码

1630510

全球注射输送装置市场

Global Injectable Drug Delivery Devices Market

出版日期: 2025年01月10日 | 出版商:

BCC Research | 英文 166 Pages | 订单完成后即时交付

价格

简介目录图表

全球注射给药装置市场规模预计将从 2024 年的 2,165 亿美元增至 2029 年的 3,172 亿美元，预测期内复合年增长率为 7.9%。

北美市场预计将从 2024 年的 773 亿美元成长到 2029 年的 1,044 亿美元，预测期内复合年增长率为 6.2%。亚太市场预计将从2024年的567亿美元成长到2029年的891亿美元，复合年增长率为9.5%。

该报告调查了全球注射输送装置市场，并提供了市场概况、市场影响因素和市场机会分析、法律制度、新兴技术和技术发展趋势、市场规模趋势和预测、各种细分和详细的区域主要企业。

新兴技术
3D列印
奈米颗粒输送系统
生物分解性和缓释系统
专利分析
专利数量（按年份）
申请人的专利
所有者的专利
发明人的专利
按司法管辖区分類的专利
临床试验分析
临床试验分析：依研究类型
临床试验分析：依状态分类
临床试验分析：按阶段

第六章市场区隔分析

按细分市场细分
全球注射输送装置市场
市场分析：依产品分类
传统注射器
先进的注射装置
市场分析：依使用类型
一次性注射器
可重复使用的注射器
市场分析：按给药途径
皮下的
肌肉注射
静脉
皮内
市场分析：依治疗应用分类
糖尿病
瘤
自体免疫疾病
其他的
市场分析：按最终用户
医院/诊所
居家照护
其他的
地域分布
市场分析：按地区
北美洲
欧洲
亚太地区
其他领域

第 7 章永续性：注射给药装置产业的 ESG 视角

概述
了解 ESG资料
环境绩效
社会表现
管治绩效
BCC的结语

第八章竞争讯息

概述
注射输送装置製造商的策略
分销网络

第九章附录

调查方法
公司简介
AMGEN INC.
ASTRAZENECA
BD
BAXTER
B. BRAUN SE
F. HOFFMANN-LA ROCHE LTD.
GERRESHEIMER AG
LILLY
MERCK & CO. INC.
MEDTRONIC
PFIZER INC.
SANOFI
TEVA PHARMACEUTICAL INDUSTRIES LTD.
TERUMO CORP.
YPSOMED
简称
来源

简介目录图表

Product Code: MDS106A

The global market for injectable drug delivery device is estimated to increase from $216.5 billion in 2024 to reach $317.2 billion by 2029, at a compound annual growth rate (CAGR) of 7.9% from 2024 through 2029.

The North American market for injectable drug delivery device is estimated to increase from $77.3 billion in 2024 to reach $104.4 billion by 2029, at a CAGR of 6.2% from 2024 through 2029.

The Asia-Pacific market for injectable drug delivery device is estimated to increase from $56.7 billion in 2024 to reach $89.1 billion by 2029, at a CAGR of 9.5% from 2024 through 2029.

Report Scope:

This report covers the global market for injectable Drug Delivery Device. It provides market projections for 2029 and analyzes the injectable Drug Delivery Device market along the following parameters: product, usage type, route of administration, therapeutic application and end users. Based on product, the injectable Drug Delivery Device market is segmented into conventional devices and advanced injectable devices. Based on usage type, the market is segmented into disposable injectors and reusable injectors. Based on the route of administration, it is segmented into subcutaneous, intramuscular, intravenous and intradermal. Based on therapeutic application, the market is segmented into diabetes, oncology, autoimmune diseases and others. Based on end user, it is segmented into hospitals and clinics, home care settings and others. The report includes a detailed competitive landscape that covers major players, market share and recent strategic developments.

Additionally, the report breaks down market trends and growth prospects across different regions. It includes market forecasts, consumer insights and a thorough supply chain analysis. By addressing distribution channels, key suppliers and other such factors, the report aims to provide a comprehensive view of the market's current state and future potential as this can help stakeholders make informed decisions and identify strategic opportunities in the injectable drug delivery device industry.

Report Includes:

46 data tables and 62 additional tables
Analyses of trends in the global market for injectable drug delivery devices, with market revenue data from 2021-2023, estimates for 2024 and projected CAGRs through 2029
Estimates of the market size and revenue growth prospects, along with a market share analysis by product, therapeutic area (application), route of administration, end user and region
Facts and figures pertaining to the market drivers, opportunities and challenges, emerging technologies and regulatory landscape
A Porter's Five Forces model, and global supply chain and PESTLE analyses
Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading companies
Review of patents and patent applications filed on drug delivery release mechanisms and novel applications
A look at the pipeline drugs, clinical trial applications and potential markets for future developments
Analysis of the competitive landscape, including companies' market shares, strategic alliances, M&A activities, and a venture funding outlook
Company profiles of major players within the industry, including BD, Sanofi, Ypsomed, Lilly, Gerresheimer AG, Medtronic, Pfizer Inc.

Chapter 1 Executive Summary

Market Outlook
Scope of Report
Market Summary

Chapter 2 Market Overview

Overview
PESTEL Analysis
Porter's Five Forces Analysis
Supply Chain Analysis
Raw Materials Sourcing
Manufacturing
Packaging and Labeling
Distribution and Logistics
Marketing, Sales, and End User

Chapter 3 Market Dynamics

Overview
Market Drivers
Increasing Prevalence of Chronic Diseases and Aging Population
Technological Advances
Patient Preference for Self-Administration
Advances in Biologics
Market Restraints
Safety Concerns
Market Opportunities
Emerging Markets
Market Challenges
Patient Compliance and Acceptance

Chapter 4 Regulatory Landscape

Overview
U.S.
EU
Japan

Chapter 5 Emerging Technologies and Developments

Emerging Technologies
3D Printing
Nanoparticle Delivery Systems
Biodegradable and Sustained Release Systems
Patent Analysis
Patents by Year
Patents by Applicant
Patents by Owner
Patents by Inventor
Patents by Jurisdiction
Clinical Trials Analysis
Clinical Trials Analysis by Type of Study
Clinical Trials Analysis by Status
Clinical Trials Analysis by Phase

Chapter 6 Market Segmentation Analysis

Segmental Breakdown
Global Market for Injectable Drug Delivery Device
Market Analysis by Product
Conventional Injectable Devices
Advanced Injectable Devices
Market Breakdown by Usage Type
Disposable Injectors
Reusable Injectors
Market Breakdown by Route of Administration
Subcutaneous
Intramuscular
Intravenous
Intradermal
Market Breakdown by Therapeutic Application
Diabetes
Oncology
Autoimmune Diseases
Other Applications
Market Breakdown by End User
Hospital and Clinics
Homecare Settings
Others
Geographic Breakdown
Market Analysis by Region
North America
Europe
Asia-Pacific
Rest of the World

Chapter 7 Sustainability: An ESG Perspective in the Injectable Drug Delivery Device Industry

Overview
Understanding the ESG Data
Environmental Performance
Social Performance
Governance Performance
Concluding Remarks from BCC

Chapter 8 Competitive Intelligence

Overview
Strategies for Injectable Drug Delivery Device Manufacturers
Distribution Networks

Chapter 9 Appendix

Methodology
Company Profiles
AMGEN INC.
ASTRAZENECA
BD
BAXTER
B. BRAUN SE
F. HOFFMANN-LA ROCHE LTD.
GERRESHEIMER AG
LILLY
MERCK & CO. INC.
MEDTRONIC
PFIZER INC.
SANOFI
TEVA PHARMACEUTICAL INDUSTRIES LTD.
TERUMO CORP.
YPSOMED
Abbreviations
Sources

简介目录图表

List of Tables

Summary Table : Global Market for Injectable Drug Delivery Device, Through 2029
Table 1 : Diabetes by Region, 2021-2045
Table 2 : Global Incidence of All Cancers, by WHO Region, 2022-2050
Table 3 : Incidence of Cancer Cases, by Cancer Type, 2022
Table 4 : Elderly Population, by Country, 2021 and 2022
Table 5 : Regulatory Approval in the U.S. and Europe
Table 6 : Patents Granted for Injectable Drug Delivery Device, by Applicant, 2021-2024*
Table 7 : Patents Granted for Injectable Drug Delivery Device, by Owner, 2021-2024*
Table 8 : Patents Granted for Injectable Drug Delivery Device, by Inventor, 2021-2024*
Table 9 : Patents Granted for Injectable Drug Delivery Device, by Jurisdiction, 2021-2024*
Table 10 : Clinical Trials in Injectable Drug Delivery Device, by Type of Study, Through November 2024
Table 11 : Clinical Trials in Injectable Drug Delivery Device, by Status, Through October 2024
Table 12 : Clinical Trials in Injectable Drug Delivery Device, by Phase, Through October 2024
Table 13 : Global Market for Injectable Drug Delivery Device, Through 2029
Table 14 : Global Market for Injectable Drug Delivery Device, by Product, Through 2029
Table 15 : Global Market for Injectable Drug Delivery Device, by Usage Type, Through 2029
Table 16 : Global Market for Injectable Drug Delivery Device, by Route of Administration, Through 2029
Table 17 : Global Market for Injectable Drug Delivery Device, by Therapeutic Application, Through 2029
Table 18 : Global Market for Injectable Drug Delivery Device, by End User, Through 2029
Table 19 : Global Market for Injectable Drug Delivery Device, by Region, Through 2029
Table 20 : North American Market for Injectable Drug Delivery Device, by Country, Through 2029
Table 21 : North American Market for Injectable Drug Delivery Device, by Product, Through 2029
Table 22 : North American Market for Injectable Drug Delivery Device, by Usage Type, Through 2029
Table 23 : North American Market for Injectable Drug Delivery Device, by Route of Administration, Through 2029
Table 24 : North American Market for Injectable Drug Delivery Device, by Therapeutic Application, Through 2029
Table 25 : North American Market for Injectable Drug Delivery Device, by End User, Through 2029
Table 26 : European Market for Injectable Drug Delivery Device, by Country, Through 2029
Table 27 : European Market for Injectable Drug Delivery Device, by Product, Through 2029
Table 28 : European Market for Injectable Drug Delivery Device, by Usage Type, Through 2029
Table 29 : European Market for Injectable Drug Delivery Device, by Route of Administration, Through 2029
Table 30 : European Market for Injectable Drug Delivery Device, by Therapeutic Application, Through 2029
Table 31 : European Market for Injectable Drug Delivery Device, by End User, Through 2029
Table 32 : Asia-Pacific Market for Injectable Drug Delivery Device, by Country, Through 2029
Table 33 : Asia-Pacific Market for Injectable Drug Delivery Device, by Product, Through 2029
Table 34 : Asia-Pacific Market for Injectable Drug Delivery Device, by Usage Type, Through 2029
Table 35 : Asia-Pacific Market for Injectable Drug Delivery Device, by Route of Administration, Through 2029
Table 36 : Asia-Pacific Market for Injectable Drug Delivery Device, by Therapeutic Application, Through 2029
Table 37 : Asia-Pacific Market for Injectable Drug Delivery Device, by End User, Through 2029
Table 38 : RoW Market for Injectable Drug Delivery Device, by Product, Through 2029
Table 39 : RoW Market for Injectable Drug Delivery Device, by Usage Type, Through 2029
Table 40 : RoW Market for Injectable Drug Delivery Device, by Route of Administration, Through 2029
Table 41 : RoW Market for Injectable Drug Delivery Device, by Therapeutic Application, Through 2029
Table 42 : RoW Market for Injectable Drug Delivery Device, by End User, Through 2029
Table 43 : ESG Rankings for Major Injectable Drug Delivery Device Companies, 2024*
Table 44 : ESG: Environmental Overview
Table 45 : ESG: Social Performance Overview
Table 46 : ESG: Governance Overview
Table 47 : Injectable Drug Delivery Device Market: Leading Players
Table 48 : Amgen Inc.: Company Snapshot
Table 49 : Amgen Inc.: Financial Performance, FY 2022 and 2023
Table 50 : Amgen Inc.: Product Portfolio
Table 51 : Amgen Inc.: News/Key Developments, 2023
Table 52 : AstraZeneca: Company Snapshot
Table 53 : AstraZeneca: Financial Performance, FY 2022 and 2023
Table 54 : AstraZeneca: Product Portfolio
Table 55 : BD: Company Snapshot
Table 56 : BD: Financial Performance, FY 2022 and 2023
Table 57 : BD: Product Portfolio
Table 58 : BD: News/Key Developments, 2022-2024
Table 59 : Baxter: Company Snapshot
Table 60 : Baxter: Financial Performance, FY 2022 and 2023
Table 61 : Baxter: Product Portfolio
Table 62 : Baxter: News/Key Developments, 2024
Table 63 : B. Braun SE: Company Snapshot
Table 64 : B. Braun SE: Financial Performance, FY 2022 and 2023
Table 65 : B. Braun SE: Product Portfolio
Table 66 : B. Braun SE: News/Key Developments, 2022-2024
Table 67 : F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 68 : F. Hoffmann-La Roche Ltd.: Financials, FY 2022 and 2023
Table 69 : F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 70 : F. Hoffmann-La Roche Ltd.: News/Key Developments, 2022-2024
Table 71 : Gerresheimer AG: Company Snapshot
Table 72 : Gerresheimer AG: Financial Performance, FY 2022 and 2023
Table 73 : Gerresheimer AG: Product Portfolio
Table 74 : Gerresheimer AG: News/Key Developments, 2022-2024
Table 75 : Lilly: Company Snapshot
Table 76 : Lilly: Financial Performance, FY 2022 and 2023
Table 77 : Lilly: Product Portfolio
Table 78 : Lilly: News/Key Developments, 2022-2024
Table 79 : Merck & Co. Inc.: Company Snapshot
Table 80 : Merck & Co. Inc.: Financial Performance, FY 2022 and 2023
Table 81 : Merck & Co. Inc.: Product Portfolio
Table 82 : Merck & Co. Inc.: News/Key Developments, 2022 and 2023
Table 83 : Medtronic: Company Snapshot
Table 84 : Medtronic: Financial Performance, FY 2022 and 2023
Table 85 : Medtronic: Product Portfolio
Table 86 : Pfizer Inc.: Company Snapshot
Table 87 : Pfizer Inc.: Financial Performance, FY 2022 and 2023
Table 88 : Pfizer Inc.: Product Portfolio
Table 89 : Pfizer Inc.: News/Key Developments, 2022
Table 90 : Sanofi: Company Snapshot
Table 91 : Sanofi: Financial Performance, FY 2022 and 2023
Table 92 : Sanofi: Product Portfolio
Table 93 : Sanofi: News/Key Developments, 2022-2024
Table 94 : Teva Pharmaceutical Industries Ltd.: Company Snapshot
Table 95 : Teva Pharmaceutical Industries Ltd.: Financial Performance, FY 2022 and 2023
Table 96 : Teva Pharmaceutical Industries Ltd.: Product Portfolio
Table 97 : Teva Pharmaceutical Industries Ltd.: News/Key Developments, 2024
Table 98 : Terumo Corp.: Company Snapshot
Table 99 : Terumo Corp.: Financial Performance, FY 2022 and 2023
Table 100 : Terumo Corp.: Product Portfolio
Table 101 : Terumo Corp.: News/Key Developments, 2022-2024
Table 102 : Ypsomed: Company Snapshot
Table 103 : Ypsomed: Financial Performance, FY 2022 and 2023
Table 104 : Ypsomed: Product Portfolio
Table 105 : Ypsomed: News/Key Developments, 2022-2024
Table 106 : Abbreviations Used in This Report
Table 107 : Report Sources

List of Figures

Summary Figure : Global Market for Injectable Drug Delivery Device, 2021-2029
Figure 1 : Supply Chain Analysis of Injectable Drug Delivery Device Industry
Figure 2 : Market Dynamics of Injectable Drug Delivery Devices
Figure 3 : Emerging Technologies in the Injectable Drug Delivery Device Market
Figure 4 : Patents Granted for Injectable Drug Delivery Device, by Year, 2021-2024*
Figure 5 : Global Market Shares of Injectable Drug Delivery Device, by Product, 2023
Figure 6 : Global Market Shares of Injectable Drug Delivery Device, by Usage Type, 2023
Figure 7 : Global Market Shares of Injectable Drug Delivery Device, by Route of Administration, 2023
Figure 8 : Global Market Shares of Injectable Drug Delivery Device, by Therapeutic Application, 2023
Figure 9 : Global Market Shares of Injectable Drug Delivery Device, by End User, 2023
Figure 10 : Global Market Shares of Injectable Drug Delivery Device, by Region, 2023
Figure 11 : North American Market Shares of Injectable Drug Delivery Device, by Country, 2023
Figure 12 : North American Market for Injectable Drug Delivery Device, 2021-2029
Figure 13 : North American Market Shares of Injectable Drug Delivery Device, by Product, 2023
Figure 14 : North American Market Shares of Injectable Drug Delivery Device, by Usage Type, 2023
Figure 15 : North American Market Shares of Injectable Drug Delivery Device, by Route of Administration, 2023
Figure 16 : North American Market Shares of Injectable Drug Delivery Device, by Therapeutic Application, 2023
Figure 17 : North American Market Shares of Injectable Drug Delivery Device, by End User, 2023
Figure 18 : European Market Shares of Injectable Drug Delivery Device, by Country, 2023
Figure 19 : European Market for Injectable Drug Delivery Device, 2021-2029
Figure 20 : European Market Shares of Injectable Drug Delivery Device, by Product, 2023
Figure 21 : European Market Shares of Injectable Drug Delivery Device, by Usage Type, 2023
Figure 22 : European Market Shares of Injectable Drug Delivery Device, by Route of Administration, 2023
Figure 23 : European Market Shares of Injectable Drug Delivery Device, by Therapeutic Application, 2023
Figure 24 : European Market Shares of Injectable Drug Delivery Device, by End User, 2023
Figure 25 : Asia-Pacific Market Shares of Injectable Drug Delivery Device, by Country, 2023
Figure 26 : Asia-Pacific Market for Injectable Drug Delivery Device, 2021-2029
Figure 27 : Asia-Pacific Market Shares of Injectable Drug Delivery Device, by Product, 2023
Figure 28 : Asia-Pacific Market Shares of Injectable Drug Delivery Device, by Usage Type, 2023
Figure 29 : Asia-Pacific Market Shares of Injectable Drug Delivery Device, by Route of Administration, 2023
Figure 30 : Asia-Pacific Market Shares of Injectable Drug Delivery Device, by Therapeutic Application, 2023
Figure 31 : Asia-Pacific Market Shares of Injectable Drug Delivery Device, by End User, 2023
Figure 32 : RoW Market for Injectable Drug Delivery Device, 2021-2029
Figure 33 : RoW Market Shares of Injectable Drug Delivery Device, by Product, 2023
Figure 34 : RoW Market Shares of Injectable Drug Delivery Device, by Usage Type, 2023
Figure 35 : RoW Market Shares of Injectable Drug Delivery Device, by Route of Administration, 2023
Figure 36 : RoW Market Shares of Injectable Drug Delivery Device, by Therapeutic Application, 2023
Figure 37 : RoW Market Shares of Injectable Drug Delivery Device, by End User, 2023
Figure 38 : ESG Metrics of Injectable Drug Delivery Device Companies
Figure 39 : Amgen Inc.: Revenue Share, by Business Unit, FY 2023
Figure 40 : Amgen Inc.: Revenue Share, by Country/Region, FY 2023
Figure 41 : AstraZeneca: Revenue Share, by Business Unit, FY 2023
Figure 42 : AstraZeneca: Revenue Share, by Region/Country, FY 2023
Figure 43 : BD: Revenue Share, by Business Unit, FY 2023
Figure 44 : BD: Revenue Share, by Country/Region, FY 2023
Figure 45 : Baxter: Revenue Share, by Business Unit, FY 2023
Figure 46 : Baxter: Revenue Share, by Country/Region, FY 2023
Figure 47 : B. Braun SE: Revenue Share, by Business Unit, FY 2023
Figure 48 : B. Braun SE: Revenue Share, by Country/Region, FY 2023
Figure 49 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Business Unit, FY 2023
Figure 50 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Country/Region, FY 2023
Figure 51 : Gerresheimer AG: Revenue Share, by Business Unit, FY 2023
Figure 52 : Gerresheimer AG: Revenue Share, by Country/Region, FY 2023
Figure 53 : Lilly: Revenue Share, by Business Unit, FY 2023
Figure 54 : Lilly: Revenue Share, by Region, FY 2023
Figure 55 : Merck & Co. Inc.: Revenue Share, by Business Unit, FY 2023
Figure 56 : Merck & Co. Inc.: Revenue Share, by Country/Region, FY 2023
Figure 57 : Medtronic: Revenue Share, by Business Unit, FY 2023
Figure 58 : Medtronic: Revenue Share, by Country/Region, FY 2023
Figure 59 : Pfizer Inc.: Revenue Share, by Business Unit, 2023
Figure 60 : Pfizer Inc.: Revenue Share, by Country/Region, 2023
Figure 61 : Sanofi: Revenue Share, by Business Unit, FY 2023
Figure 62 : Sanofi: Revenue Share, by Country/Region, FY 2023
Figure 63 : Teva Pharmaceutical Industries Ltd.: Revenue Share, by Business Unit, FY 2023
Figure 64 : Teva Pharmaceutical Industries Ltd.: Revenue Share, by Country/Region, 2023
Figure 65 : Terumo Corp.: Revenue Share, by Country/Region, FY 2023
Figure 66 : Terumo Corp.: Revenue Share, by Business Unit, FY 2023
Figure 67 : Ypsomed: Revenue Share, by Business Unit, FY 2023
Figure 68 : Ypsomed: Revenue Share, by Country/Region, FY 2023